107 related articles for article (PubMed ID: 10803532)
21. Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type.
Chen W; Jones D; Medeiros LJ; Luthra R; Lin P
Br J Haematol; 2005 Sep; 130(5):726-8. PubMed ID: 16115128
[TBL] [Abstract][Full Text] [Related]
22. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.
Whitman SP; Archer KJ; Feng L; Baldus C; Becknell B; Carlson BD; Carroll AJ; Mrózek K; Vardiman JW; George SL; Kolitz JE; Larson RA; Bloomfield CD; Caligiuri MA
Cancer Res; 2001 Oct; 61(19):7233-9. PubMed ID: 11585760
[TBL] [Abstract][Full Text] [Related]
23. Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA.
Jilani I; Estey E; Manshuri T; Caligiuri M; Keating M; Giles F; Thomas D; Kantarjian H; Albitar M
Leukemia; 2003 Jan; 17(1):114-9. PubMed ID: 12529667
[TBL] [Abstract][Full Text] [Related]
24. FLT3-TKD mutation in childhood acute myeloid leukemia.
Liang DC; Shih LY; Hung IJ; Yang CP; Chen SH; Jaing TH; Liu HC; Wang LY; Chang WH
Leukemia; 2003 May; 17(5):883-6. PubMed ID: 12750701
[TBL] [Abstract][Full Text] [Related]
25. FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group.
Abu-Duhier FM; Goodeve AC; Wilson GA; Gari MA; Peake IR; Rees DC; Vandenberghe EA; Winship PR; Reilly JT
Br J Haematol; 2000 Oct; 111(1):190-5. PubMed ID: 11091200
[TBL] [Abstract][Full Text] [Related]
26. FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia.
Arrigoni P; Beretta C; Silvestri D; Rossi V; Rizzari C; Valsecchi MG; Cazzaniga G; Biondi A
Br J Haematol; 2003 Jan; 120(1):89-92. PubMed ID: 12492581
[TBL] [Abstract][Full Text] [Related]
27. AML1B transcriptional repressor function is impaired by the Flt3-internal tandem duplication.
Takahashi S; Harigae H; Kameoka J; Sasaki T; Kaku M
Br J Haematol; 2005 Aug; 130(3):428-36. PubMed ID: 16042694
[TBL] [Abstract][Full Text] [Related]
28. FLT3 inhibition as tailored therapy for acute myeloid leukemia.
Martinelli G; Piccaluga PP; Lo Coco F
Haematologica; 2003 Jan; 88(1):4-8. PubMed ID: 12551818
[No Abstract] [Full Text] [Related]
29. Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemia.
Kottaridis PD; Gale RE; Linch DC
Leuk Lymphoma; 2003 Jun; 44(6):905-13. PubMed ID: 12854887
[TBL] [Abstract][Full Text] [Related]
30. The expression of FMS, KIT and FLT3 in hematopoietic malignancies.
Birg F; Rosnet O; Carbuccia N; Birnbaum D
Leuk Lymphoma; 1994 Apr; 13(3-4):223-7. PubMed ID: 7519507
[TBL] [Abstract][Full Text] [Related]
31. Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assay.
Murphy KM; Levis M; Hafez MJ; Geiger T; Cooper LC; Smith BD; Small D; Berg KD
J Mol Diagn; 2003 May; 5(2):96-102. PubMed ID: 12707374
[TBL] [Abstract][Full Text] [Related]
32. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.
Shih LY; Huang CF; Wang PN; Wu JH; Lin TL; Dunn P; Kuo MC
Leukemia; 2004 Mar; 18(3):466-75. PubMed ID: 14737077
[TBL] [Abstract][Full Text] [Related]
33. The FLT3 internal tandem duplication mutation prevents apoptosis in interleukin-3-deprived BaF3 cells due to protein kinase A and ribosomal S6 kinase 1-mediated BAD phosphorylation at serine 112.
Yang X; Liu L; Sternberg D; Tang L; Galinsky I; DeAngelo D; Stone R
Cancer Res; 2005 Aug; 65(16):7338-47. PubMed ID: 16103085
[TBL] [Abstract][Full Text] [Related]
34. [Prevalence and clinical significance of FLT3 internal tandem duplication mutation in acute leukemia].
Wang LH; Zhou CL; Zhang XW; Chen S; Wang M; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):393-6. PubMed ID: 15355689
[TBL] [Abstract][Full Text] [Related]
35. No correlation between trisomy 13 and FLT3 duplication in acute myeloid leukemia.
Powell H; Curtis A; Bown N; Taylor P
Cancer Genet Cytogenet; 2005 Jan; 156(1):92-3. PubMed ID: 15588866
[No Abstract] [Full Text] [Related]
36. Flt3 mutations and leukaemia.
Kottaridis PD; Gale RE; Linch DC
Br J Haematol; 2003 Aug; 122(4):523-38. PubMed ID: 12899708
[No Abstract] [Full Text] [Related]
37. Low frequency of FLT3 gene internal tandem duplication and activating loop mutation in therapy-related acute myelocyticleukemia and myelodysplastic syndrome.
Au WY; Fung AT; Ma ES; Liang RH; Kwong YL
Cancer Genet Cytogenet; 2004 Mar; 149(2):169-72. PubMed ID: 15036894
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis.
Yanada M; Matsuo K; Suzuki T; Kiyoi H; Naoe T
Leukemia; 2005 Aug; 19(8):1345-9. PubMed ID: 15959528
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia.
Kang HJ; Hong SH; Kim IH; Park BK; Han KS; Cho HI; Shin HY; Ahn HS
Leuk Res; 2005 Jun; 29(6):617-23. PubMed ID: 15863200
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenomics suggests new treatment approach for leukaemia.
Senior K
Drug Discov Today; 2002 Aug; 7(15):791-2. PubMed ID: 12546960
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
